in vivo Training Initiative
This scheme was originally developed in response to the document published by the ABPI on the current shortage in in-vivo skills.
The aim of this scheme is to give students training and experience in in-vivo skills in psychopharmacology and related neuroscience fields. We aim to provide supervisors with some flexibility across the academic year to provide this training and to facilitate Psychopharmacology-related projects that may not have existing funding.
These applications will be supervisor led and awards must be spent by the specified deadline. A total of 4 projects will be available with up to £5,000 available to support each project. BAP can provide animals from Envigo who have generously agreed to reduce the costs of animal purchase for this scheme.
The BAP is delighted to announce the 2020 round of its new funding initiative to encourage and support pre-clinical research in the UK and provide opportunity to train in in-vivo skills.
How To Apply
- Supervisors, who must be BAP members, are invited to complete the online application form, submit a short CV (2 pages) and a research proposal (approx. 500 words) with full costing for the project.
- Supervisors must ensure the student receives adequate training and both student and project meet all statutory requirements for the work to be undertaken.
- Student recruitment will be the responsibility of the supervisor, but the scheme is aimed specifically at pre-PhD students who may be considering PhD study and is explicitly not intended to support students already registered for PhD or masters components of PhD students or their projects.
- The application deadline is 8th April 2020.
Project Criteria and Assessment
- The project must be based in a UK or ROI institution and the proposed use of animals in the project should comply with the Home Office regulations and ethical standards under the Animals Scientific Procedures Act 1986/ European directive 2010/63/EU on the protection of animals used for scientific purposes.
- The project must be one that involves whole animals (in vivo) and fits within the remit of the BAP – to advance research in the science of psychopharmacology.
- In addition to psychopharmacology, related disciplines including neuroscience/genetics/psychiatry/neurology and animal welfare projects are encouraged, provided they include a strong component of in-vivo training.
- All applications will be reviewed blind to the identity of the applicant and assessed on the quality of the proposed project and the quality of the training experience the student will receive.
- Projects will be funded up to a total of £5,000 per project and must include a stipend for the student.
- The funds on offer are to be specifically used for student stipend (mandatory), animal maintenance costs, consumables and Home Office personal licence fees as necessary (as required by the project).
- Payment of the funds will be made directly to the University or Institution.
- For the 2020 funding round the deadline for receiving applications is 8th April 2020 and all applicants will be informed of the outcomes in May. Funds will be available to successful award holders until 31st July 2021.
- Recipients of the BAP project funds (supervisor or student) will normally be required to present a poster or oral communication at the BAP annual summer meeting.
- A final jointly authored report (approx. 500 words) will be required from the supervisor and student to provide feedback to the BAP to allow evaluation of the initiative. This report will made available to download on the website.
- Recipients will be asked to evaluate the scheme and provide feedback to BAP to enable further development of the in-vivo training initiative.
One award was made in 2019 to Dr Steven Clapcote, School of Biomedical Science, Leeds ‘Behavioural and pharmacological characterisation of a novel neurone-specific Na,K-ATPase mutant mouse model’ – the Panel highlighted the range of in vivo behavioural tests the student will be exposed to alongside pharmacological manipulations; the Panel thought the project would provide important information in a new transgenic model with potential translational relevance for a devastating illness.
Application Deadline: 8th April 2020